Research Project

Project Title:	Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) (I CAN)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression.
Lead principal investigator(s):	Smaragdi Marinaki, Athens
Co-investigator(s):	Stathis Tsiakas, Athens Chrysanthi Skalioti, Athens Christina Melexopoulou, Athens
Project Period:	04/2024 - 10/2029
Sponsors:	Industry
Project web page:	https://igan.org/clinical-trial/alxn1210-igan-320-study/
ClinicalTrials.gov:	NCT06291376
EudraCT Nr.:	2023-507851-31-00